Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127284231 | 12728423 | 1 | I | 201507 | 20160901 | 20160909 | 20160909 | EXP | NL-LRB-224954 | NL-PFIZER INC-2016416058 | PFIZER | 58.00 | YR | F | Y | 71.00000 | KG | 20160909 | CN | NL | NL |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127284231 | 12728423 | 1 | PS | SULFASALAZINE. | SULFASALAZINE | 1 | Oral | 1000 MG, 2X/DAY | Y | 7073 | 1000 | MG | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127284231 | 12728423 | 1 | Rheumatic disorder |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127284231 | 12728423 | OT |
| 127284231 | 12728423 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127284231 | 12728423 | Abdominal pain upper | |
| 127284231 | 12728423 | Hepatic enzyme abnormal | |
| 127284231 | 12728423 | Nausea | |
| 127284231 | 12728423 | Vomiting | |
| 127284231 | 12728423 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127284231 | 12728423 | 1 | 201507 | 0 |